Yale Rep Establishes Center for New Theatre

This article is from the archive of The New York Sun before the launch of its new website in 2022. The Sun has neither altered nor updated such articles but will seek to correct any errors, mis-categorizations or other problems introduced during transfer.

The New York Sun

New-play commissioning and development are about to ramp up at Yale Repertory Theatre, which is establishing the Yale Center for New Theatre with a $2.85 million grant from the Minnesota-based Robina Foundation.

With the center, which Yale Rep and the Yale School of Drama announced Wednesday, the theater will up the number of its commissions of plays and musicals, and host residencies, readings, workshops, and full productions of commissioned pieces. The center will also help to establish playwrights’ residencies as lecturers at the drama school, which will develop curriculum in writing for musical theater.

The grant will not all be spent in New Haven, however. It includes a $600,000 fund, to be administered by the center, to support other nonprofit theaters producing world-premiere or second productions of plays commissioned by Yale Rep through the center.

Current Yale Rep commissions include a Dostoyevsky adaptation by Robert Woodruff and Bill Camp; original plays by David Adjmi, Hilary Bell, Marcus Gardley, Amy Herzog, Naomi Iizuka, Rolin Jones, Elizabeth Meriwether, Octavio Solis, Kate Walat, Anne Washburn, and Marisa Wegrzyn, and a musical by Adam Bock and Todd Almond.

Pulitzer Prize winner Paula Vogel, recently appointed Eugene O’Neill Professor and Chair of Playwriting at the drama school, has been named playwright in residence at Yale Rep.


The New York Sun

© 2025 The New York Sun Company, LLC. All rights reserved.

Use of this site constitutes acceptance of our Terms of Use and Privacy Policy. The material on this site is protected by copyright law and may not be reproduced, distributed, transmitted, cached or otherwise used.

The New York Sun

Sign in or  Create a free account

or
By continuing you agree to our Privacy Policy and Terms of Use